scispace - formally typeset
D

David Baxter

Researcher at University of Manchester

Publications -  87
Citations -  4459

David Baxter is an academic researcher from University of Manchester. The author has contributed to research in topics: Vaccination & Electric vehicle. The author has an hindex of 31, co-authored 85 publications receiving 3682 citations. Previous affiliations of David Baxter include Manchester Academic Health Science Centre & Baxter International.

Papers
More filters
Journal ArticleDOI

Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

Alasdair Munro, +314 more
- 02 Dec 2021 - 
TL;DR: The COV-BOOST trial as mentioned in this paper investigated the reactogenicity and immunogenicity of seven different COVID-19 vaccines as a third dose after two doses of ChAdOx1 nCov-19 (Oxford-AstraZeneca; hereafter referred to as ChAd) or BNT162b2 (Pfizer-BioNtech, hearafter referred to As BNT).
Journal ArticleDOI

Social Behavior and Meningococcal Carriage in British Teenagers

TL;DR: Attention at pubs/clubs, intimate kissing, and cigarette smoking were each independently and strongly associated with increased risk for meningococcal carriage, but age, sex, social deprivation, home crowding, or school characteristics had little or no effect.
Journal ArticleDOI

Active and passive immunity, vaccine types, excipients and licensing

TL;DR: This article reviews active and passive immunity and the differences between them and describes the four different commercially available vaccine types (live attenuated, killed/inactivated, subunit and toxoid) and looks at how these different vaccines generate an adaptive immune response.